Clinical Trial Update: A Study of Mitoxantrone Hydrochloride Liposome Infusion [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a liposomal mitoxantrone formulation being studied in Non-Hodgkin lymphoma in Phase 1/Phase 2; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Mitoxantrone hydrochloride liposome infusion (mitoxantrone liposome)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN